Joshua D Waetzig

This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Blueprint Medicines Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshua D Waetzig. Retrieved from https://idiyas.com/inventor/joshua-d-waetzig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3 (Patent Applications = 5)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

3 out of 72

Blueprint Medicines Corporation

patents

Years Active: 2024

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12060354 - Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making (2024-08-13),

2. 11999744 - Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making (2024-06-04),

3. 11964980 - Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making (2024-04-23),

Title: **The Innovative Contributions of Joshua D. Waetzig**

Introduction

Joshua D. Waetzig is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing novel compounds and their crystalline forms, which hold promise in treating various medical disorders.

Latest Patents

Joshua D. Waetzig holds three patents, with his latest innovations centering around crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine. These patents disclose methods for creating pharmaceutically acceptable salts, solvates, and pharmaceutical compositions for treating disorders associated with oncogenic KIT and PDGFRA alterations. His research also includes the methods for producing these compounds and their crystalline forms.

Career Highlights

Joshua is currently affiliated with Blueprint Medicines Corporation, where he applies his expertise to advance innovative pharmaceutical solutions. His focus on developing effective therapeutic agents showcases his commitment to improving healthcare outcomes through scientific innovation.

Collaborations

In his role, Joshua D. Waetzig collaborates with talented professionals including his coworker, Gordon Wilkie. Their joint efforts are pivotal in driving the research and development of advanced pharmaceutical products.

Conclusion

Joshua D. Waetzig exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only represent significant technical achievements but also highlight the potential impact of his work on the treatment of serious medical conditions. As he continues to push the boundaries of scientific research, the contributions of inventors like him play a crucial role in shaping the future of medicine.

Profile summary based on public USPTO records.